Release Date: 22/08/12 08:02 Summary: Preliminary Final Report Price Sensitive: Yes Download Document 634.03KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%